Study Of An Investigational Drug For Advanced Relapsed, Refractory, Or Resistant Hematological (Blood) Cancer
Seeking men and women with advanced relapsed, refractory, or resistant hematological (blood) cancer with an IDH mutation that has not responded or stopped responding to prior treatment for participation in a study of an investigational drug.